A focus on PD-L1 in human melanoma.

@article{Hersey2013AFO,
  title={A focus on PD-L1 in human melanoma.},
  author={Peter Hersey and Stuart J Gallagher},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2013},
  volume={19 3},
  pages={514-6}
}
Treatment of metastatic melanoma with inhibitors of the BRAF V600 oncogene in melanoma has been limited by the development of resistance. Combining the BRAF inhibitors with immunotherapy may prolong the response, but will acquisition of resistance to BRAF inhibitors also make melanoma cells resistant to immunotherapy? 

1 Figure or Table

Topic